Search Results 761-770 of 18213 for creatine evidence

1. Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer - Mayo Clinic

   Serum creatinine < 1.5 mg/dL. Serum Creatinine:______ ... Patients must not have clinical evidence of inflammatory disease or fixed axillary nodes at diagnosis.

2. Efficacy Of Daromun Neoadjuvant Intratumoral Treatment In Clinical Stage IIIB/C Melanoma Patients

   Serum creatinine < 1.5 x ULN . LDH serum level ... Evidence of a personally signed and dated ... Evidence of distant metastases at screening.

3. Ixazomib Citrate, Lenalidomide, Dexamethasone, and Zoledronic Acid or Zoledronic Acid Alone After Radiation Therapy in Treating Patients With Solitary Plasmacytoma of Bone - Mayo Clinic

   Serum Creatinine < 2.0 mg/dL [176.8 µmol/liter];; Serum calcium ≤ 11.5 mg/dL;; Calc. Creatinine Clearance > 50 mL/min; ... There is no evidence of hepatic damage ...

4. Safety and Tolerability Study of SNS01-T in Relapsed or Refractory B Cell Malignancies (Multiple Myeloma, B Cell Lymphoma, or Plasma Cell Leukemia (PCL) - Mayo Clinic

   Evidence of end-organ damage that can be ... Renal insufficiency: serum creatinine >2mg/dL ... Have serum creatinine ≤3 times the upper limit of normal ...

5. Study of the EZH2 Inhibitor Tazemetostat in Malignant Mesothelioma - Mayo Clinic

   Part 2: Molecular evidence of BAP1 loss of function ... evidence of loss of function by gene sequencing ... Creatinine < 2.0 × ULN; Hepatic function ...

6. Randomized, Open Label, Clinical Study of the Targeted Therapy, Palbociclib, to Treat Metastatic Breast Cancer

   ... evidence for recurrence of the breast cancer. Patients must have ... Serum creatinine below the upper limit of normal (ULN) of the institutional normal range or ...

7. Ginseng as an Intervention to Decrease Cancer-Related Fatigue in Post-Treatment Cancer Survivors - Mayo Clinic

   Treatment has been completed (except hormone therapy) for ≥90 days prior to registration. No known evidence of disease ... Creatinine ≤1.2 X ULN. Ability ...

8. Calcineurin Inhibitor-Free Interventions for Prevention of Graft-versus-Host Disease (BMT CTN 1301) - Mayo Clinic

   ... evidence of dyspnea and no need for supplemental oxygen, as evidenced by O2 saturation ≥ 92% on room air. Liver function: total bilirubin < 2x the upper ...

9. A Study to Compare the Effectiveness, Safety and Tolerability of P1101 vs. Anagrelide for Essential Thrombocythemia - Mayo Clinic

   Creatinine clearance ≥40 mL/min (by Cockcroft-Gault equation) ... Evidence of severe retinopathy (e.g., cytomegalovirus retinitis, macular ... History or evidence ...

10. Medical Research & Education - Mayo Clinic News Network

    Understanding the effects of, and using social media to improve evidence-based practice. Joel Streed. March 17, 2022. Mayo Clinic researchers use AI to predict ...